News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Immunicum Recruits a New Chief Operating Officer


7/1/2013 7:44:29 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Immunicum AB (publ), which develops therapeutic cancer vaccines, has appointed Henrik Elofsson as new Chief Operating Officer (COO).

As COO, Henrik Elofsson will be responsible for project management regarding preclinical and clinical trials. He will also be responsible for the establishment of a large-scale production process.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES